Ameliorative potential of aliskiren in experimental colitis in mice

European Journal of Pharmacology

Volumn 737, Issue , 2014, Pages 70-76

  Patel, Rakesh B ^a   Prajapati, Kanaiyalal D ^a   Sonara, Bhavin M ^a   Sharma, Manoranjan M ^a   Patel, Hiren M ^a   Pawar, Vishwanath D ^a   Jain, Mukul R ^a  

^a ZYDUS RESEARCH CENTRE   (India)

Author keywords

Aliskiren; Colitis; DSS; m RNA; Renin

Indexed keywords

ALISKIREN; HEMOGLOBIN; INTERLEUKIN 6; MALONALDEHYDE; MESSENGER RNA; MYELOPEROXIDASE; RENIN; TUMOR NECROSIS FACTOR ALPHA; AMIDE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CYTOKINE; DEXTRAN SULFATE; FUMARIC ACID DERIVATIVE; PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; COLON LENGTH; COLON WEIGHT; COLON WEIGHT LENGTH RATIO; CONTROLLED STUDY; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; DISEASE SEVERITY; DRUG EFFECT; ERYTHROCYTE COUNT; FECES ANALYSIS; FEMALE; FOOD INTAKE; GENE EXPRESSION; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGAN WEIGHT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECTUM HEMORRHAGE; RENIN GENE; SCORING SYSTEM; SEQUENCE ANALYSIS; SPLEEN WEIGHT; WEIGHT REDUCTION; ANIMAL; BLOOD; BODY WEIGHT; CHEMICALLY INDUCED; COLITIS; COLON; DRUG EFFECTS; EATING; ERYTHROCYTE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; ORGAN SIZE; PATHOLOGY; SPLEEN;

AMIDES; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BODY WEIGHT; COLITIS; COLON; CYTOKINES; DEXTRAN SULFATE; EATING; ERYTHROCYTES; FEMALE; FUMARATES; GENE EXPRESSION REGULATION; HEMATOCRIT; HEMOGLOBINS; MALONDIALDEHYDE; MICE; ORGAN SIZE; PEROXIDASE; RENIN; RNA, MESSENGER; SPLEEN;

EID: 84901729152     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.05.009     Document Type: Article

References (51)

1. R. Atreya, J. Mudter, S. Finotto, J. Mullberg, T. Jostock, S. Wirtz, M. Schutz, B. Bartsch, M. Holtmann, C. Becker, D. Strand, J. Czaja, J.F. Schlaak, H.A. Lehr, F. Autschbach, G. Schurmann, N. Nishimoto, K. Yoshizaki, H. Ito, T. Kishimoto, P.R. Galle, S. Rose-John, and M.F. Neurath Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn's disease and experimental colitis in vivo Nat. Med. 6 2000 583 588 (Pubitemid 30305911)
2. M. Azizi, J. Ménard, A. Bissery, T.T. Guyene, and A. Bura-Rivière Hormonal and hemodynamic effects of aliskiren and valsartan and their combination in sodium-replete normotensive individuals Clin. J. Am. Soc. Nephrol. 2 2007 947 955
3. I.M. Bassim Hepatoprotective potential of nebivolol and aliskiren on methotrexate induced liver toxicity Med. J. Babylon 7 2010 563 570
4. R.S. Blumberg, L.J. Saubermann, and W. Strober Animal models of mucosal inflammation and their relation to human inflammatory bowel disease Curr. Opin. Immunol. 11 1999 648 656
5. 1 receptor antagonism prevent stress-induced gastric injury Am. J. Physiol. Gastrointest. Liver Physiol. 285 2003 G414 G423
6. L.A. Campos, M. Bader, and O.C. Baltatu Brain renin-angiotensin system in hypertension, cardiac hypertrophy, and heart failure Front. Physiol. 2 2011 115
7. A.H. Danser The increase in renin during renin inhibition: does it result in harmful effects by the (pro)renin receptor? Hypertens. Res. 33 2010 4 10
8. A. Del Fiorentino, S. Cianchetti, A. Celi, and R. Pedrinelli Aliskiren, a renin inhibitor, downregulates TNF-alphainduced tissue factor expression in HUVECS J. Renin Angiotensin Aldosterone Syst. 11 2010 243 247
9. L.A. Dieleman, M.J. Palmen, H. Akol, E. Bloemena, A.S. Pena, S.G. Meuwissen, and E.P. Van Rees Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines Clin. Exp. Immunol. 114 1998 385 391 (Pubitemid 28539597)
10. D.L. Feldman, L. Jin, H. Xuan, A. Contrepas, Y. Zhou, R.L. Webb, D.N. Mueller, S. Feldt, F. Cumin, W. Maniara, E. Persohn, H. Schuetz, A.H. Jan Danser, and G. Nguyen Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats Hypertension 52 2008 130 136
11. N.R. Ferreri, B.A. Escalante, Y. Zhao, S.J. An, and J.C. McGiff Angiotensin II induces TNF production by the thick ascending limb: functional implications Am. J. Physiol. 274 1998 F148 F155
12. C. Fiocchi Inflammatory bowel disease: etiology and pathogenesis Gastroenterology 115 1998 182 205 (Pubitemid 28307304)
13. B.A. Hendrickson, R. Gokhale, and J.H. Cho Clinical aspects and pathophysiology of inflammatory bowel disease Clin. Microbiol. Rev. 15 2002 79 94 (Pubitemid 34052583)
14. Y. Higashikuni, M. Takaoka, H. Iwata, K. Tanaka, Y. Hirata, R. Nagai, and M. Sata Aliskiren in combination with valsartan exerts synergistic protective effects against ventricular remodeling after myocardial infarction in mice Hypertens. Res. 35 2012 62 69
15. Y.C. Hsieh, C.C. Chan, K.C. Lee, Y.T. Huang, F.Y. Lee, Y.Y. Yang, and H.C. Lin Aliskiren reduces portal pressure and intrahepatic resistance in biliary cirrhotic rats J. Chin. Med. Assoc. 75 2012 501 508
16. J. Ino, C. Kojima, M. Osaka, K. Nitta, and M. Yoshida Dynamic observation of mechanically-injured mouse femoral artery reveals an antiinflammatory effect of renin inhibitor Arterioscler. Thromb. Vasc. Biol. 29 2009 1858 1863
17. Y. Inokuchi, T. Morohashi, I. Kawana, Y. Nagashima, M. Kihara, and S. Umemura Amelioration of 2,4,6-trinitrobenzene sulphonic acid induced colitis in angiotensinogen gene knockout mice Gut 54 2005 349 356 (Pubitemid 40299090)
18. H. Ito, M. Takazoe, Y. Fukuda, T. Hibi, K. Kusugami, A. Andoh, T. Matsumoto, T. Yamamura, J. Azuma, N. Nishimoto, K. Yoshizaki, T. Shimoyama, and T. Kishimoto A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease Gastroenterology 126 2004 989 996 (Pubitemid 38451170)
19. N. Jahovic, F. Ercan, N. Gedik, M. Yuksel, G. Sener, and I. Alican The effect of angiotensin-converting enzyme inhibitors on experimental colitis in rats Regul. Pept. 130 2005 67 74 (Pubitemid 40966024)
20. R. Jaszewski, V. Tolia, M.N. Ehrinpreis, J.H. Bodzin, R.R. Peleman, R. Korlipara, and J.V. Weinstock Increased colonic mucosal angiotensin I and II concentrations in Crohn's colitis Gastroenterology 98 1990 1543 1548 (Pubitemid 20158619)
21. B. Johansson, M. Holm, S. Ewert, A. Casselbrant, A. Pettersson, and L. Fandriks Angiotensin II type 2 receptor-mediated duodenal mucosal alkaline secretion in the rat Am. J. Physiol. Gastrointest. Liver Physiol. 280 2001 G1254 G1260
22. C.I. Johnston, J.A. Millar, B.P. Mcgrath, and P.G. Matthews Long-term effects of captopril (SQ14 225) on blood pressure and hormone levels in essential hypertension Lancet 2 1979 493 496
23. M.R. Jones, J.E. Sealey, and J.H. Laragh Effects of angiotensin receptor blockers on ambulatory plasma Renin activity in healthy, normal subjects during unrestricted sodium intake Am. J. Hypertens. 20 2007 907 916 (Pubitemid 47176356)
24. A. Keshavarzian, G. Morgan, S. Sedghi, J.H. Gordon, and M. Doria Role of reactive oxygen metabolites in experimental colitis Gut 31 1990 786 790 (Pubitemid 20233945)
25. M.M. Lawson, A.G. Thomas, and A.K. Akobeng Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis Cochrane Database Syst. Rev. 19 2006 CD005112
26. S.J. Lee, and K.T. Lim Glycoprotein isolated from Ulmus davidiana Nakai regulates expression of iNOS and COX-2 in vivo and in vitro Food Chem. Toxicol. 45 2007 990 1000
27. A. Levin, and O. Shibolet Infliximab in ulcerative colitis Biologics 2 2008 379 388
28. O.H. Lowry, N.J. Rosenbrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
29. H. Lu, D.L. Rateri, D.L. Feldman, R.J. Charnigo Jr., A. Fukamizu, J. Ishida, E.G. Oesterling, L.A. Cassis, and A. Daugherty Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice J. Clin. Invest. 118 2008 984 993 (Pubitemid 351364606)
30. L.C. Matavelli, J. Huang, and H.M. Siragy (Pro)renin receptor contributes to diabetic nephropathy by enhancing renal inflammation Clin. Exp. Pharmacol. Physiol. 37 2010 277 282
31. T. Moriyama, M. Fujibayashi, Y. Fujiwara, T. Kaneko, C. Xia, E. Imai, T. Kamada, A. Ando, and N. Ueda Angiotensin II stimulates interleukin-6 release from cultured mouse mesangial cells J. Am. Soc. Nephrol. 6 1995 95 101
32. A. Nakamura, E.J. Johns, A. Imaizumi, Y. Yanagawa, and T. Kohsaka Effect of beta(2)-adrenoceptor activation and angiotensin II on tumour necrosis factor and interleukin 6 gene transcription in the rat renal resident macrophage cells Cytokine 11 1999 759 765 (Pubitemid 29460474)
33. H. Ohkawa, N. Ohishi, and K. Yagi Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal. Biochem. 95 1979 351 358 (Pubitemid 9194347)
34. I. Okayasu, S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki, and R. Nakaya A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice Gastroenterology 98 1990 694 702 (Pubitemid 20069706)
35. R.B. Patel, V.D. Pawar, K.D. Prajapati, B.M. Sonara, S.S. Deshpande, G.B. Shah, and M.R. Jain Anti-nociceptive and anti-allodynic activity of aliskiren in various pain models Eur. J. Pharmacol. 708 2013 80 87
36. W.E. Pullman, S. Elsbury, M. Kobayashi, A.J. Hapel, and W.F. Doe Enhanced mucosal cytokine production in inflammatory bowel disease Gastroenterology 102 1992 529 537
37. C. Rojas-Cartagena, I. Flores, and C.B. Appleyard Role of tumor necrosis factor receptors in an animal model of acute colitis Cytokine 32 2005 85 93 (Pubitemid 41563038)
38. M. Ruiz-Ortega, O. Lorenzo, Y. Suzuki, M. Ruperez, and J. Egido Proinflammatory actions of angiotensins Curr. Opin. Nephrol. Hypertens. 10 2001 321 329 (Pubitemid 32424019)
39. M.G. Russel Changes in the incidence of inflammatory bowel disease: what does it mean? Eur. J. Intern. Med. 11 2000 191 196
40. O.I. Santiago, E. Rivera, L. Ferder, and C.B. Appleyard An angiotensin II receptor antagonist reduces inflammatory parameters in two models of colitis Regul. Pept. 146 2008 250 259
41. K. Schmerbach, T. Pfab, Y. Zhao, J. Culman, S. Mueller, A. Villringer, D.N. Muller, B. Hocher, T. Unger, and C. Thoene-Reineke Effects of aliskiren on stroke in rats expressing human renin and angiotensinogen genes PLoS One 5 2010 e15052
42. B. Siegmund, F. Rieder, S. Albrich, K. Wolf, C. Bidlingmaier, G.S. Firestein, D. Boyle, H.A. Lehr, F. Loher, G. Hartmann, S. Endres, and A. Eigler Adenosine kinase inhibitor GP515 improves experimental colitis in mice J. Pharmacol. Exp. Ther. 296 2001 99 105 (Pubitemid 32015066)
43. W. Strober, I.J. Fuss, and R.S. Blumberg The immunology of mucosal models of inflammation Annu. Rev. Immunol. 20 2002 495 549 (Pubitemid 34293433)
44. C.Y. Sun, W.J. Cherng, H.Z. Jian, H.H. Hsu, I.W. Wu, H.J. Hsu, and M.S. Wu Aliskiren reduced renal fibrosis in mice with chronic ischemic kidney injury-beyond the direct renin inhibition Hypertens. Res. 35 2012 304 311
45. S.C. Tang, M. Lin, S. Tam, W.S. Au, M.K. Ma, D.Y. Yap, Y.W. Ho, and K.N. Lai Aliskiren combined with losartan in immunoglobulin A nephropathy: an open-labeled pilot study Nephrol. Dial. Transplant. 27 2012 613 618
46. D. Wengrower, G. Zanninelli, O. Pappo, G. Latella, M. Sestieri, A. Villanova, Y. Faitelson, M. Pines, and E. Goldin Prevention of fibrosis in experimental colitis by captopril: the role of TGF-β1 Inflamm. Bowel Dis. 10 2004 536 545 (Pubitemid 39276460)
47. B. Williams Angiotensin II and the pathophysiology of cardiovascular remodeling Am. J. Cardiol. 87 2001 10C 17C (Pubitemid 32385757)
48. S. Wirtz, and M.F. Neurath Mouse models of inflammatory bowel disease Adv. Drug Deliv. Rev. 59 2007 1073 1083 (Pubitemid 47615208)
49. J.M. Wood, F. Cumin, and J. Maibaum Pharmacology of renin inhibitors and their application to the treatment of hypertension Pharmacol. Ther. 61 1994 325 344 (Pubitemid 24207703)
50. M. Yamamoto, K. Yoshizaki, T. Kishimoto, and H. Ito IL-6 is required for the development of Th1 cell-mediated murine colitis J. Immunol. 164 2000 4878 4882 (Pubitemid 30238092)
51. Y. Zhang, Y. Wang, Y. Chen, D.K. Deb, T. Sun, Q. Zhao, and Y.C. Li Inhibition of renin activity by aliskiren ameliorates diabetic nephropathy in type 1 diabetes mouse model J. Diabetes Mellit. 2 3 2012 353 360